Arsenal Biosciences
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredSep 5, 2017 (9 years old)
Funding rounds
- Series B+ · amount undisclosedSource: fundraisingfox.com
- Website created
Companies like Arsenal Biosciences
CCatalYm$150M Series B+ · Jul 2024
AA2 Biotherapeutics$80M Series B+ · Jan 2025
WWaypoint Bio$20M Series A · Jun 2026
TT-Knife$110M Series B+ · Aug 2021
BBreakthru Medicine$60M Series A · Feb 2026
AAkamis Bio$60M Series A · Dec 2024
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arsenal-biosciences (get a free API key).